Positive Clinical Interim Results
...completed its ‘first-in-human’ clinical trial...
Feature Article - Australian Investor Magazine
...making dramatic moves with new CEO...
Commencing Human Clinical Trials of Cuprindo™
...clinical trials of Cuprindo™ to determine its safety...
Clinical collaboration agreement signed, 4 Jun 07
....for up to three GI indications....
Sucessful Settlement of Dispute
...MTY successfully settled its dispute with The University of Sydney...
Latest Shareholder Update, 1 Feb 08
...Welcome to this second edition of MTY News...


Medical Therapies Ltd
(MTY):

POSITIVE INTERIM RESULTS FROM CUPRINDO™ PHASE 1 CLINICAL TRIALS

15th February 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), today announced that it has completed its ‘first-in-human’ clinical trial of Cuprindo™ to determine its safety, tolerability and systemic absorption characteristics. The Phase 1 trial was conducted using a topical suppository formulation in preparation for a planned efficacy study in proctitis patients.

To read more...download from here a copy of the ASX announcement

© Medical Therapies
Web design company
Medical Therapies Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@medicaltherapies.com.au